Journal
EMERGING INFECTIOUS DISEASES
Volume 23, Issue 11, Pages 1852-1855Publisher
CENTERS DISEASE CONTROL
DOI: 10.3201/eid2311.170561
Keywords
-
Categories
Funding
- Commissioned Health and Medical Research Fund (Phase 3) of the Food and Health Bureau of the Hong Kong Special Administrative Region [CU-15-C2]
Ask authors/readers for more resources
A new recombinant norovirus GII. P16-GII.2 outnumbered pandemic GII.4 as the predominant GII genotype in the winter of 2016-2017 in Hong Kong, China. Half of hospitalized case-patients were older children and adults, including 13 young adults. This emergent norovirus targets a wider age population compared with circulating pandemic GII.4 strains.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
